The Journal of Allergy and Clinical Immunology: Global (JACI: Global), a new Gold Open Access journal from the American Academy of Allergy, Asthma & Immunology (AAAAI), is now accepting manuscript submissions at the journal’s submission portal at editorialmanager.com/jacig. The first issue of JACI: Global will publish in February 2022 during the AAAAI Annual Meeting in Phoenix, Arizona.
JACI: Global is currently seeking papers covering basic and bench science, translational studies in early or developmental stages of research, regional studies in allergy / immunology (A/I), research with an international focus on A/I, case series or case reports that demonstrate a novel, impactful insight, and papers covering new research in A/I.
As the Gold Open Access companion journal to AAAAI’s two leading hybrid subscription journals, JACI and JACI: In Practice, JACI: Global will provide authors a high-quality outlet for authors whose funders require them to publish open access as a condition of their funding. It also provides researchers whose work is sound science, but does not meet the criteria of the other AAAAI journals the opportunity to publish in a journal that will reach a global audience, with no barrier to access for anyone with an internet connection.
Dr. David B. Peden will serve a 5-year term as the inaugural Editor-in-Chief of the journal. In addition to being a past President of the AAAAI, he is the Harry S. Andrews Professor of Pediatrics, Medicine and Microbiology and Immunology at the University of North Carolina (UNC) School of Medicine, and a member of the UNC Children’s Research Center. He also serves as Senior Associate Dean for Translational Research and Medical Director for the Center for Environmental Medicine, Asthma & Lung Biology at the UNC School of Medicine.
Click here to read the original press release.
